MAAT INDEX

CLAIM #18132 · CVS Health Corp (CVS) · 2022Q3 earnings call · Nov 2, 2022 · due Dec 31, 2024

I am confident that we have the activities, the investment and approach to mitigate stars for 2024.

Karen Lynch · CEO

PENDING
graded after results covering Dec 31, 2024 are reported

In context

good example of that. bswift is a good example of that. And as Shawn said earlier this year, we made divestitures as part of our international business and Payflex as well. Regarding stars, and I'll let Shawn talk about the financials in a second. Just a comment on stars, I would just say kind of across the industry, everyone was challenged with stars, and we were extremely disappointed in our 3.5 star rating plan. But as you know, we have been a very strong leader in stars performance for a decade. And we continue to invest. We will continue to invest in our star performance. We have a number of actions relative to the CAP survey and member scores, which is really part of the driver. We do have a diversification effort. I'll ask Dan to talk about what we're specifically doing there. But I am confident that we have the activities, the investment and approach to mitigate stars for 2024. And with that, let me turn it to Shawn to talk about the divestitures and then Dan will pick up on stars. Shawn Guertin : Okay. Just on the -- so on the divestitures and obviously, this is -- the timing of all this is still to be determined. But I think if successful on Omnicare, there's probably another $0.02 or $0.03 potentially that I would add to that $0.04 that I described in the bridge for divested asset. Again, not something that I think that would change our outlook on our range. But when you're thinking about the baseline, it would be a small sort of a small additional item. But again, 1 we think is navigable for 2023. And obviously, we think this is the right long-term thing strategically to do for the business. Signify, we will -- when we get to the closing, we'll talk more sp

Verify independently

SEC filings for CVS · Claim quote is verbatim from the 2022Q3 earnings call.